Hong Kong Suspends Order Of AstraZeneca Jabs

"); jQuery("#212 h3").html("

Related News Programmes

"); jQuery(document).ready(function() { jwplayer.key='EKOtdBrvhiKxeOU807UIF56TaHWapYjKnFiG7ipl3gw='; var playerInstance = jwplayer("jquery_jwplayer_1"); playerInstance.setup({ file: "https://newsstatic.rthk.hk/audios/mfile_1584928_1_20210409182352.mp3", skin: { url: location.href.split('/', 4).join('/') + '/jwplayer/skin/rthk/five.css', name: 'five' }, hlshtml: true, width: "100%", height: 30, wmode: 'transparent', primary: navigator.userAgent.indexOf("Trident")>-1 ? "flash" : "html5", events: { onPlay: function(event) { dcsMultiTrack('DCS.dcsuri', 'https://news.rthk.hk/rthk/en/component/k2/1584928-20210409.mp3', 'WT.ti', ' Audio at newsfeed', 'WT.cg_n', '#rthknews', 'WT.cg_s', 'Multimedia','WT.es','https://news.rthk.hk/rthk/en/component/k2/1584928-20210409.htm', 'DCS.dcsqry', '' ); } } }); }); });

2021-04-09 HKT 13:11

Share this story

facebook

  • Hong Kong suspends order of AstraZeneca jabs

Health Secretary Sophia Chan said on Friday that the government will delay shipments of AstraZeneca's Covid-19 vaccine this year, amid mounting concerns over possible links between the shot and very rare cases of blood clots.

The government has ordered 7.5 million doses from the British-Swedish company and they were scheduled to arrive in the second half of 2021.

But Chan said the territory already has a sufficient supply of vaccines, after the delivery of 15 million doses of Germany's BioNTech and China's Sinovac.

"Even if we have signed a pre-purchase agreement with AstraZeneca, we believe that AstraZeneca vaccines will not need to be supplied to Hong Kong this year, so as not to cause a waste when the vaccine is still in short supply globally," Chan said.

The government was considering buying a new type of vaccine that may offer better protection, she added.

More than 700,000 Covid-19 vaccine doses have been administered to the city's 7.5 million population so far, a figure Chief Executive Carrie Lam said was unsatisfactory.

The sluggish take-up comes amid dwindling confidence in the Sinovac vaccine and fears of adverse reactions, while BioNTech vaccines were temporarily halted due to packaging defects. (Reuters)

RECENT NEWS

StartmeupHK Festival And Hong Kong Fintech Week 2025 Merge For 10th Anniversary Milestone

Invest Hong Kong (InvestHK) announced on 10 March 2025 that both of its flagship events, Hong Kong Fintech Week 2025 an... Read more

Ant AI-Powered Health Insurance Processes 7.25M Claims In 2024, 55%YoY Increase

In 2024, Ant Insurance, the online insurance brokerage platform of Ant Group, processed 7.25 million health claims, mar... Read more

Ping An Talent Uses AI For Job Matching, But Can Technology Make Recruitment Fairer?

Ping An Insurance (Group) Company of China, Ltd. has launched its 2025 Spring Campus Recruitment, offering over 2,000 p... Read more

HKEX Partners With CMU OmniClear To Boost Post-Trade Securities Infrastructure

Hong Kong Exchanges and Clearing Limited (HKEX) announced on 4 March 2025 that it signed a Memorandum of Understanding ... Read more

PAObank Secures Insurance Agency Licence, Partners With Ping An And FWD Hong Kong

PAO Bank Limited (PAObank) has received its Insurance Agency Licence from the Insurance Authority and signed strategic ... Read more

IFAST Launches Self-Service Accounts For Hong Kong Family Offices

Fintech solutions provider iFAST HK launches self-service accounts in Hong Kong, catering to the growing demand for ind... Read more